Pay for Performance…and Gender?
Posted by DeeDee DeMan - After a year at the helm of GlaxoSmithKline, CEO Emma Walmsley earned a $1.3 million bump in pay in 2018, mostly due to pay for performance. The jump takes her to $7.67 million and makes her the highest-paid woman on...
Regarding Scott Gottlieb’s Tenure as FDA Commissioner
One of the few beacons of light emanating out of Washington DC has been Scott Gottlieb. In less than two years, Scott and his team have redefined both what it takes, and what it is, to be a courageous leader who takes the road less...
Bench International’s DeeDee DeMan and Kristine Mayle named to Murrieta Genomics Inaugural Advisory Board
Murrieta Genomics, the genomic sequencing business incubator, has released details of its Advisory Board. The Board will bring industry specific and broader business experience to bear as genomic sequencing startups build their business models. Read more --> https://bit.ly/2W0g3PD...
Immuno-oncology is primed to be one of the market’s hottest industries
Posted by DeeDee DeMan - When we think of the most competitive industries in the marketplace today, app creation, custom software development and other tech companies certainly come to mind. One we don’t think about often, however, is immuno-oncology, and we should, because this market is...
Avoiding the celebrity crush to build a better board
Posted by DeeDee DeMan - A film starring Leonardo DiCaprio is apt to do better at the box office than one that doesn’t feature his talents, and LeBron James has been to the NBA Finals eight years in a row. The moral? Big names can yield...
Bolstering the board room: Why the addition of women is integral
Posted by DeeDee DeMan – For generations the appearance of a company's board was very … homogeneous. Entirely white. Entirely male. In the last few years, however, women and people of color are finally being allowed the opportunity to make their mark on company boards. There’s...
Recent Key Placement: Chief Executive Officer – BioTme, Inc.
BioTime Implements New Leadership Structure; Appoints Brian Culley as Chief Executive Officer Read BioTime's Press Release: http://investor.biotimeinc.com/phoenix.zhtml?c=83805&p=irol-newsArticle_Print&ID=2367846...
Preparation, preparation, preparation!
Posted by: Natasha Allen, SVP & General Manager UK, Bench Despite the British sense of humor this article caught my attention and struck a cord with our philosophy here at Bench, that preparedness is the key to success. We have been vocal about keeping a stronghold...
Patients reaping the benefits of great collaboration advancements in Digital Health.
Posted by: Natasha Allen, SVP & General Manager UK, Bench International I read this article a couple of day ago, which then lead to reading numerous others, it is wonderful to see so many organizations taking positive steps to address and provide patient friendly and workable...
Recent Key Placement: Chief Medical Officer – ImmusanT, Inc
As Bench International continues to fulfill its mission of bringing the finest leaders to high impact, emerging growth companies, we are very pleased to announce the appointment of Ken Truitt, MD as Chief Medical Officer for ImmusanT. ImmusanT_Ken-Truitt_press-release_FINAL...